MediGene Company

MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.

Investors

Technology: Atrificial Vectors and Immune Cells, Cell-based gene therapy, Dendritic Cells
Industry: Atrificial Vectors and Immune Cells, Dendritic Cells, Public
Headquarters: Martinsried, Bayern, Germany
Founded Date: 1994-01-01
Employees Number: 51-100
Funding Status: IPO
Investors Number: 1
Total Funding: 26000000
Estimated Revenue: $10M to $50M
Last Funding Date: 2022-02-02
Last Funding Type: Post-IPO Equity

Visit Website
medigene@medigene.com
https://www.twitter.com/medigeneag
Register and Claim Ownership